HS Code:
Rubber catheters, classified under HS Code 4014.90, are medical devices made from natural or synthetic rubber used primarily for urinary drainage or other medical procedures. These products are critical in healthcare settings, particularly for patients with urinary incontinence or those undergoing surgical procedures. The global trade of rubber catheters is driven by demand in the healthcare sector, aging populations, and advancements in medical technology. This category includes both sterile and non-sterile variants, with varying levels of customization based on medical requirements.
Total Trade Volume
USD 1.2 billion
Data from 2022
Source
UN Comtrade Database, International Trade Centre (ITC)
USD 320 million
26.7% of total trade of total trade
Increasing
USD 180 million
15.0% of total trade of total trade
Stable
USD 150 million
12.5% of total trade of total trade
Increasing
USD 100 million
8.3% of total trade of total trade
Increasing
USD 80 million
6.7% of total trade of total trade
Stable
Average Rate
6.5% ad valorem
Highest Rate
15% (applied by certain developing countries)
Lowest Rate
0% (under free trade agreements like EU-USMCA)
Rising demand due to aging population
Increased imports in developed countries with higher elderly demographics, such as the US and Japan, driving market growth by 5-7% annually.
2022
Shift towards eco-friendly materials
Manufacturers are exploring biodegradable and latex-free alternatives, influencing trade patterns as countries prioritize sustainable medical products.
2021-2022
Technological advancements in catheter design
Innovations like antimicrobial coatings are increasing the value per unit, impacting export revenues for technologically advanced countries like Germany and the US.
2022
A bilateral agreement reduced tariffs on medical rubber products, including catheters, to facilitate smoother trade and address supply chain disruptions caused by the COVID-19 pandemic.
March 2022
Increased export volumes from China to the US by approximately 10% in 2022, stabilizing prices for end consumers.
The EU implemented stricter regulations under the Medical Device Regulation (MDR) framework, requiring enhanced documentation and compliance for rubber catheter imports.
May 2021
Temporary slowdown in imports to the EU as manufacturers adapt to new standards, with a projected recovery by mid-2023.
Malaysia introduced subsidies for rubber-based medical product exporters to boost competitiveness in the global market.
January 2022
Led to a 15% increase in Malaysia's rubber catheter exports, positioning it as a key supplier in Southeast Asia.